These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Intractable epilepsies. An open trial with Clobazam.
    Author: Cornaggia CM, Cattabeni G, Cerisola N, Leozappa C, Mascetti PL, Massironi R, Porro G, Manghi E.
    Journal: Acta Neurol (Napoli); 1989 Feb; 11(1):1-9. PubMed ID: 2655375.
    Abstract:
    Clobazam was used as an added treatment in 28 patients with intractable epilepsies: 26 subjects had associated handicaps. A good response was observed during the first two-three months of Clobazam treatment: the reduction in seizure frequency of 73% for partial seizures and 62% for GTCs. A tolerance to Clobazam treatment was observed after the third month of treatment: at the end of the sixth month, the seizure frequency was reduced to 36% for partial seizures and 39% for GTCs. Out of 28 patients 4 were seizure free at the end of the sixth month; we have not found any specific characteristic in these patients. The AA. suggest the possibility of an intermittent use of Clobazam for this type of patients.
    [Abstract] [Full Text] [Related] [New Search]